Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Published in: Clinical and Translational Oncology 9/2015

01-09-2015 | Research Article

The effect of enhanced recovery program for patients undergoing partial laparoscopic hepatectomy of liver cancer

Authors: F. He, X. Lin, F. Xie, Y. Huang, R. Yuan

Published in: Clinical and Translational Oncology | Issue 9/2015

Login to get access

Abstract

Objective

To analyze the results after the introduction of enhanced recovery after surgery (ERAS) protocols, a randomized study was performed to compare the outcomes of laparoscopic hepatectomy under ERAS or traditional care.

Methods

Patients undergoing laparoscopic hepatectomy from April 2014 to October 2014 were included and randomly divided into Control group (CG) and ERAS. Primary outcome was quality of life (QoL) and length of hospital stay (LOS). Secondary endpoints were percentage readmission, mortality, duration to first flatus, complications, hospital costs, conversions and blood loss.

Results

Thirteen patients withdrew after randomization. Eighty-six patients completed the study, 48 ERAS and 38 CG. Postoperative LOS was significantly reduced in ERAS [6 (4–8) versus 10 (7–15) days, P = 0.04]. First flatus occurred earlier in ERAS than CG [2(1–4) versus 3(2–5) days, P = 0.02]. The average perioperative charges were 9470 ± 1540 in CG and only 7742 ± 1200 in ERAS (P = 0.03), with no differences in readmission rate, blood loss, conversions to open surgery, mortality or surgical complications. The median AUC (area under a curve) of QoL was considerably improved in ERAS (P = 0.04).

Conclusions

This study suggests that ERAS is feasible and safe for laparoscopic hepatectomy.
Literature
1.
Kehlet H. Multimodal approach to control postoperative pathophysiology and rehabilitation. Br J Anaesth. 1997;78(5):606–17.PubMedCrossRef
2.
Fayezizadeh M, Petro CC, Rosen MJ, Novitsky YW. Enhanced recovery after surgery pathway for abdominal wall reconstruction: pilot study and preliminary outcomes. Plast Reconstr Surg. 2014;134(4 Suppl 2):151S–9S.PubMedCrossRef
3.
4.
Aarts MA, Okrainec A, Glicksman A, Pearsall E, Victor JC, McLeod RS. Adoption of enhanced recovery after surgery (ERAS) strategies for colorectal surgery at academic teaching hospitals and impact on total length of hospital stay. Surg Endosc. 2012;26(2):442–50.PubMedCrossRef
5.
Kim JW, Kim WS, Cheong JH, Hyung WJ, Choi SH, Noh SH. Safety and efficacy of fast-track surgery in laparoscopic distal gastrectomy for gastric cancer: a randomized clinical trial. World J Surg. 2012;36(12):2879–87.PubMedCrossRef
6.
Wang G, Jiang ZW, Xu J, Gong JF, Bao Y, Xie LF, et al. Fast-track rehabilitation program vs conventional care after colorectal resection: a randomized clinical trial. World J Gastroenterol. 2011;17(5):671–6.PubMedCentralPubMedCrossRef
7.
Yang D, He W, Zhang S, Chen H, Zhang C, He Y. Fast-track surgery improves postoperative clinical recovery and immunity after elective surgery for colorectal carcinoma: randomized controlled clinical trial. World J Surg. 2012;36(8):1874–80.PubMedCentralPubMedCrossRef
8.
Cuesta MA, Meijer S, Paul MA, de Brauw LM. Limited laparoscopic liver resection of benign tumors guided by laparoscopic ultrasonography: report of two cases. Surg Laparosc Endosc. 1995;5(5):396–401.PubMed
9.
Shibata J, Ishihara S, Nishikawa T, Tanaka T, Tanaka J, Kiyomatsu T, et al. Minimally invasive surgery for rectal cancer. Nihon Shokakibyo Gakkai Zasshi. 2014;111(11):2105–12.PubMed
10.
van Gulik T. Open versus laparoscopic resection for liver tumours. HPB (Oxford). 2009;11(6):465–8.CrossRef
11.
Rockall TA, Demartines N. Laparoscopy in the era of enhanced recovery. Best Pract Res Clin Gastroenterol. 2014;28(1):133–42.PubMedCrossRef
12.
Abu Hilal M, Pearce NW. Laparoscopic left lateral liver sectionectomy: a safe, efficient, reproducible technique. Dig Surg. 2008;25(4):305–8.PubMedCrossRef
13.
van Dam RM, Wong-Lun-Hing EM, van Breukelen GJ, Stoot JH, van der Vorst JR, Bemelmans MH, et al. Open versus laparoscopic left lateral hepatic sectionectomy within an enhanced recovery ERAS(R) programme (ORANGE II-trial): study protocol for a randomised controlled trial. Trials. 2012;13:54.PubMedCentralPubMedCrossRef
14.
Dagher I, O’Rourke N, Geller DA, Cherqui D, Belli G, Gamblin TC, et al. Laparoscopic major hepatectomy: an evolution in standard of care. Ann Surg. 2009;250(5):856–60.PubMedCrossRef
15.
Lin DX, Li X, Ye QW, Lin F, Li LL, Zhang QY. Implementation of a fast-track clinical pathway decreases postoperative length of stay and hospital charges for liver resection. Cell Biochem Biophys. 2011;61(2):413–9.PubMedCentralPubMedCrossRef
16.
MacKay G, O’Dwyer PJ. Early discharge following liver resection for colorectal metastases. Scott Med J. 2008;53(2):22–4.PubMedCrossRef
17.
Sanchez-Perez B, Aranda-Narvaez JM, Suarez-Munoz MA, Eladel-Delfresno M, Fernandez-Aguilar JL, Perez-Daga JA, et al. Fast-track program in laparoscopic liver surgery: theory or fact? World J Gastrointest Surg. 2012;4(11):246–50.PubMedCentralPubMedCrossRef
18.
Schultz NA, Larsen PN, Klarskov B, Plum LM, Frederiksen HJ, Christensen BM, et al. Evaluation of a fast-track programme for patients undergoing liver resection. Br J Surg. 2013;100(1):138–43.PubMedCrossRef
19.
Jones C, Kelliher L, Dickinson M, Riga A, Worthington T, Scott MJ, et al. Randomized clinical trial on enhanced recovery versus standard care following open liver resection. Br J Surg. 2013;100(8):1015–24.PubMedCrossRef
20.
Langenhoff BS, Krabbe PF, Peerenboom L, Wobbes T, Ruers TJ. Quality of life after surgical treatment of colorectal liver metastases. Br J Surg. 2006;93(8):1007–14.PubMedCrossRef
21.
Shao Y, Zou LL, Zhou QH, Zhong DS, Guo FJ, Ma L. Fast-track surgery for gastroenteric neoplasms: a meta-analysis. Tumori. 2014;100(5):197e–203e.
22.
Buell JF, Cherqui D, Geller DA, O’Rourke N, Iannitti D, Dagher I, et al. The international position on laparoscopic liver surgery: The Louisville Statement, 2008. Ann Surg. 2009;250(5):825–30.PubMedCrossRef
23.
Nguyen KT, Gamblin TC, Geller DA. World review of laparoscopic liver resection 2804 patients. Ann Surg. 2009;250(5):831–41.PubMedCrossRef
24.
Philp S, Carter J, Pather S, Barnett C, D’Abrew N, White K. Patients’ satisfaction with fast-track surgery in gynaecological oncology. Eur J Cancer Care (Engl). 2014. doi:10.​1111/​ecc.​12254.
25.
Khan S, Gatt M, MacFie J. Enhanced recovery programmes and colorectal surgery: does the laparoscope confer additional advantages? Colorectal Dis. 2009;11(9):902–8.PubMedCrossRef
26.
Holte K, Sharrock NE, Kehlet H. Pathophysiology and clinical implications of perioperative fluid excess. Br J Anaesth. 2002;89(4):622–32.PubMedCrossRef
27.
Gustafsson UO, Hausel J, Thorell A, Ljungqvist O, Soop M, Nygren J, et al. Adherence to the enhanced recovery after surgery protocol and outcomes after colorectal cancer surgery. Arch Surg. 2011;146(5):571–7.PubMedCrossRef
28.
Wakeling HG, McFall MR, Jenkins CS, Woods WG, Miles WF, Barclay GR, et al. Intraoperative oesophageal Doppler guided fluid management shortens postoperative hospital stay after major bowel surgery. Br J Anaesth. 2005;95(5):634–42.PubMedCrossRef
29.
Koea JB, Young Y, Gunn K. Fast track liver resection: the effect of a comprehensive care package and analgesia with single dose intrathecal morphine with gabapentin or continuous epidural analgesia. HPB Surg. 2009;2009:271986.PubMedCentralPubMedCrossRef
30.
Bagry HS, Raghavendran S, Carli F. Metabolic syndrome and insulin resistance: perioperative considerations. Anesthesiology. 2008;108(3):506–23.PubMedCrossRef
31.
Soop M, Carlson GL, Hopkinson J, Clarke S, Thorell A, Nygren J, et al. Randomized clinical trial of the effects of immediate enteral nutrition on metabolic responses to major colorectal surgery in an enhanced recovery protocol. Br J Surg. 2004;91(9):1138–45.PubMedCrossRef
32.
Stevens MF, de Nes L, Hollmann MW. Randomized clinical trial of epidural, spinal or patient-controlled analgesia for patients undergoing laparoscopic colorectal surgery (Br J Surg 2011; 98: 1068–1078). Br J Surg. 2011;98(12):1805 author reply 6.PubMedCrossRef
33.
Pearse R, Dawson D, Fawcett J, Rhodes A, Grounds RM, Bennett ED. Early goal-directed therapy after major surgery reduces complications and duration of hospital stay. A randomised, controlled trial [ISRCTN38797445]. Crit Care. 2005;9(6):R687–93.PubMedCentralPubMedCrossRef
34.
Rahbari NN, Zimmermann JB, Schmidt T, Koch M, Weigand MA, Weitz J. Meta-analysis of standard, restrictive and supplemental fluid administration in colorectal surgery. Br J Surg. 2009;96(4):331–41.PubMedCrossRef
35.
Itou K, Fukuyama T, Sasabuchi Y, Yasuda H, Suzuki N, Hinenoya H, et al. Safety and efficacy of oral rehydration therapy until 2 h before surgery: a multicenter randomized controlled trial. J Anesth. 2012;26(1):20–7.PubMedCentralPubMedCrossRef
36.
Camera L, Calabrese M, Sarnelli G, Longobardi M, Rocco A, Cuomo R, et al. Pseudopneumoperitoneum in chronic intestinal pseudo-obstruction: a case report. World J Gastroenterol. 2011;17(24):2972–5.PubMedCentralPubMedCrossRef
37.
Alkari B, Owera A, Ammori BJ. Laparoscopic liver resection: preliminary results from a UK centre. Surg Endosc. 2008;22(10):2201–7.PubMedCrossRef
38.
Khan S, Wilson T, Ahmed J, Owais A, MacFie J. Quality of life and patient satisfaction with enhanced recovery protocols. Colorectal Dis. 2010;12(12):1175–82.PubMedCrossRef
39.
Spanjersberg WR, Reurings J, Keus F, van Laarhoven CJ. Fast track surgery versus conventional recovery strategies for colorectal surgery. Cochrane Database Syst Rev. 2011;2:CD007635.PubMed
Metadata
Title
The effect of enhanced recovery program for patients undergoing partial laparoscopic hepatectomy of liver cancer
Authors
F. He
X. Lin
F. Xie
Y. Huang
R. Yuan
Publication date
01-09-2015
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 9/2015
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-015-1296-9

Other articles of this Issue 9/2015

Clinical and Translational Oncology 9/2015 Go to the issue

Research Article

A phase II study of feasibility and toxicity of bevacizumab in combination with temozolomide in patients with recurrent glioblastoma

Review Article

Identification of circulating MicroRNAs as novel potential biomarkers for hepatocellular carcinoma detection: a systematic review and meta-analysis

Research Article

Association of ERCC1 polymorphisms (rs3212986 and rs11615) with the risk of head and neck carcinomas based on case–control studies

Brief Research Article

RAS status in Korean patients with stage III and IV colorectal cancer

Research Article

Clinical outcome of cisplatin-based chemotherapy is associated with the polymorphisms of GSTP1 and XRCC1 in advanced non-small cell lung cancer patients

Research Article

Efficacy of platinum combination chemotherapy after first-line gefitinib treatment in non-small cell lung cancer patients harboring sensitive EGFR mutations
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits